Enterprise Solutions Webinars
-
Idea To Clinic: Accelerate Your Manufacturing Timeline To FIH Studies
3/11/2024
Translating novel drug discoveries into clinical trials remains a complex endeavor. Learn how a CDMO with cutting-edge technologies can facilitate a smooth path from discovery to FIH studies.
-
Single-Use Microbial Impactor On A Filling Line
3/6/2024
Discover the advantages of a single-use microbial impactor through a demonstration of its ease of use in an isolator and an explanation of its ability to eliminate false positives.
-
Accelerating Rare Disease Treatments From Concept To Cure
2/29/2024
Access a thorough investigation that delves into the critical aspects of expediting curative therapies, with a focus on the strategic role that CDMOs can play in this transformative journey.
-
Abzena Capacity Update February 2024: Large Molecule
2/28/2024
Hear expert insight from Abzena’s CTO on how to de-risk and streamline the development of your biopharmaceutical in order to successfully meet your next regulatory or clinical milestone.
-
Ajinomoto Bio-Pharma Services Capacity Update February 2024: Small Molecule
2/28/2024
Explore the recent expansions of Ajinomoto BPS. Our experts delve into the advancements in our development and manufacturing capabilities for HPAPI, clinical development, and late-stage projects.
-
Nanoform Capacity Update February 2024: Small Molecule
2/28/2024
Discover Nanoform’s manufacturing capabilities, its CESS technology for nanoparticle generation, and the types of particles that can be generated without the need for solvents or excipients.
-
EirGenix Inc. Capacity Update February 2024: Large Molecule
2/28/2024
EirGenix has immediate availability of capacity up to 12 x 2,000 L SUBs for mammalian cells and up to 150 L scale for microbial and that will increase to 350L and 1,000L by end of this year.
-
Resilience US, Inc. Capacity Update February 2024: Large Molecule
2/28/2024
With a strong network of sites, Resilience provides innovative solutions and services for established and emerging therapies. Learn how we can support your development and manufacturing programs.
-
KBI Biopharma Capacity Update February 2024: Large Molecule
2/28/2024
Learn how KBI Biopharma is equipped to support drug development and biologics manufacturing and accelerate your timeline.
-
Simtra BioPharma Solutions Capacity Update February 2024: Large Molecule
2/28/2024
Simtra currently has open capacity for liquid vial projects at both manufacturing sites and can support rapid tech transfer depending on the complexity of the project and the availability of materials.